BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26795349)

  • 21. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
    Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
    Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
    Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
    Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.
    Day KC; Lorenzatti Hiles G; Kozminsky M; Dawsey SJ; Paul A; Broses LJ; Shah R; Kunja LP; Hall C; Palanisamy N; Daignault-Newton S; El-Sawy L; Wilson SJ; Chou A; Ignatoski KW; Keller E; Thomas D; Nagrath S; Morgan T; Day ML
    Cancer Res; 2017 Jan; 77(1):74-85. PubMed ID: 27793843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
    Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
    J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
    Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
    Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
    Wang L; Alcon A; Yuan H; Ho J; Li QJ; Martins-Green M
    Integr Biol (Camb); 2011 Jul; 3(7):742-54. PubMed ID: 21594291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model.
    Ueda T; Ito S; Shiraishi T; Kulkarni P; Ueno A; Nakagawa H; Kimura Y; Hongo F; Kamoi K; Kawauchi A; Miki T
    Prostate; 2013 Sep; 73(13):1403-12. PubMed ID: 23765687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
    Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer.
    Campodónico PB; de Kier Joffé ED; Urtreger AJ; Lauria LS; Lastiri JM; Puricelli LI; Todaro LB
    Mol Carcinog; 2010 Apr; 49(4):386-97. PubMed ID: 20191608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
    Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
    Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of the metastasis-associated gene Ehm2 in prostate cancer.
    Wang J; Cai Y; Penland R; Chauhan S; Miesfeld RL; Ittmann M
    Prostate; 2006 Nov; 66(15):1641-52. PubMed ID: 16927306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.